康泰生物：2023年度社会责任报告暨ESG（环境、社会及公司治理）报告（英文版）.PDF

1、Reporting PrinciplesIt follows the reporting principles,including:Basis of the ReportThe report has been compiled in accordance with the Guidelines on the Content and Format of Information Disclosure by Companies Publicly Issuing Securities No.2-Content and Format of Annual Reports by the China Secu

2、rities Regulatory Commission(CSRC),and the Guidelines on Self-regulation of Listed Companies on Shenzhen Stock Exchange No.2-Standardized Operation of Listed Companies on the ChiNext Market,the Guidelines on Self-regulation of Listed Companies on Shenzhen Stock Exchange No.1-Business Processing by t

3、he Shenzhen Stock Exchange(SZSE)and other relevant regulations.Scope of the ReportOrganizational scopeThe report covers Shenzhen Kangtai Biological Products Co.,Ltd.(BioKangtai,or the Company)and its subsidiary,which is in line with the scope of the Companys annual report and consolidated financial

4、statements.Full NameAbbreviationsShenzhen Kangtai Biological Products Co.,Ltd.BioKangtai,the CompanyBeijing Minhai Biotechnology Co.,Ltd.BioMinhaiTime scopeFrom January 1,2023,to December 31,2023,with some representations and information being traced back to previous years as appropriate.Data Descri

5、ptionIf not otherwise stated,the financial data disclosed in the report are derived from the audited financial report of the Company and other data are obtained from the Companys internal statistics and relevant documents.The currency type in the report is Chinese Yuan(CNY),and amounts covered in th

6、e report are in Chinese yuan.Report LanguageThe report is written in two languages,Chinese and English.If there is any discrepancy between the two versions,the Chinese version shall prevail.About this ReportPrinciple of MaterialityThis report identifies and responds to material issues that are conce